Smith & Nephew casts off DermaGraft while orthopaedics still stands strong
This article was originally published in Clinica
Executive Summary
Smith & Nephew is packing up its DermaGraft business after the US FDA unexpectedly refused to approve the woundcare product for treatment of venous leg ulcers.